VEGF receptor signaling and endothelial function

IUBMB Life

Volumn 52, Issue 1-2, 2001, Pages 61-66

  Kliche, S ^a   Waltenberger, J ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Angiogenesis; Arteriogenesis; Flt 1; KDR Flk 1; Nitric oxide; VEGF; VEGF receptors; VEGF signaling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; HUMANS; LYMPHOKINES; NITRIC OXIDE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036137466     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540252774784     Document Type: Conference Paper

References (101)

1. Mechanisms of angiogenesis
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Proteolytic processing regulates receptor specificity and activity of VEGF-C
4. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
5. Impaired collateral vessel development in diabetes: Potential cellular mechanisms and therapeutic implications
6. HIV-tat protein is a heparin-binding angiogenic growth factor
7. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
8. Genomic organization of the mouse and human genes for vascular endothelial growth factor (VEGF-B) and characterization of a second splice isoform
9. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor
10. Tumor induction of VEGF promoter activity in stromal cells
11. Regulation of angiogenesis via vascular endothelial growth factor receptors
12. Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site
13. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor
14. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
15. Both v-Ha-Ras and v-Raf stimulate expression of the vascular growth endothelial growth factor in NIH3T3 cells
16. Pieces of eight: Bioactive fragments of extracellular proteins as regulators of angiogenesis
17. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
18. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
19. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not Flk-1/KDR
20. The carboxy-terminal domain of vascular endothelial growth factor is critical for its mitogenic potency
21. Vascularization of the mouse embryo: A development
22. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
23. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
24. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
25. The biology of vascular endothelial growth factor
26. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
27. Vaslular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
28. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
29. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and flt in lungs exposed to acute and chronic hypoxia. Modulation of gene expression by nitric oxide
30. Dimerization, DNA binding and transactivation properties of hypoxia inducible factor 1
31. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and ist receptors
32. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14
33. Inhibition of lymphangiogenesis with resulting lymphedma in transgenic mice expressing soluble VEGF receptor-3
34. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
35. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus
36. Signaling angiogenesis and lymphangiogenesis
37. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
38. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta
39. Placenta growth factor: Potential role in pregnancy
40. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/endothelial growth factor
41. VEGF145, a secreted vascular endothelial cell isoform, that binds to extracellular matrix
42. Growth factor signaling by receptor tyrosine kinases
43. Role of VEGF-FLT receptor system in normal and tumor angiogenesis
44. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
45. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4)
46. A novel type of vascular endothelial growth factor VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
47. A novel vascular endothelial growth factor encoded by orf virus, VEGF-E mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR- 1 (Flt-1) receptor tyrosine kinases
48. Vascular endothelial growth factor and ist receptors
49. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding any may initiate a signal transduction cascade
50. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
51. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
52. Regulation der endothelfunktion und der angiogenese durch den vaskulhren endothelialen wachstums faktor-A (VEGF-A)
53. Signaling transduction mechanism mediating biological actions of the vascular endothelial growth factor family
54. Differential signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor
55. Dimerization of cell surface receptors in signal transduction
56. Protein modules and signaling networks
57. A novel function of the vascular endothelial growth factor receptor-2 (KDR): Rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells
58. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2
59. 2+ mobilization in human umbilical vein endothelial cells
60. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
61. Inhibition of vascular endothelial growth factor activity by an endogenously encoded soluble receptor
62. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2
63. Receptor chimeras indicate that the vascular endothelial growth factor receptor I (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
64. VPF/VEGF receptor-1 down modulates VPF/VEGF receptor-2 mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase dependent pathways
65. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibts vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration
66. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinases/Akt signal transduction pathway. Requirement of Flk-1/KDR activation
67. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
68. The role of phosphatidylinositol 3′ kinase in vascular endothelial growth factor signaling
69. Marked induction of the IAP antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
70. Vascular endothelial growth factor stimulates tryosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells
71. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
72. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular-signal-regulated kinasel/2 activation in postcapillary endothelium
73. ERK/JUN kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation
74. Functional upregulation of the vascular growth factor receptor KDR by hypoxia
75. 2 in endothelial cells via p42/p44 mitogen activated protein kinases
76. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases
77. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
78. 2+
79. Inhibition of vascular endothelial growth factor-induced migration by ETS1 antisense oligonucleotides
80. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant tie-2 causing venous malformations signals distinct STAT activation response
81. Vascular endothelial growth factor-induced tissue factor expression in endothelial cells
82. Role of vascular endothelial growth factor in regulation of physiological angiogenesis
83. FGF and VEGF function in angiogenesis signalling pathways, biological responses and therapeutic inhibition
84. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase
85. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase
86. P38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganisation and cell migration in human endothelial cells
87. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells
88. Nitric oxide modulation of focal adhesions in endothelial cells
89. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
90. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
91. VEGF gene transfer reduces initial thickening via increased production of nitric oxide in carotid arteries
92. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
93. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium
94. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
95. Vascular protection: A novel, non-angiogenic cardiovascular role for vascular endothelial growth factor
96. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells
97. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells
98. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and protein kinase C signaling pathway
99. Regulation of endothjelium-derived nitric oxide production by the protein kinase Akt
100. Role of HIF- 1 alpha in hypoxia mediated apoptosis, cell proliferation, and tumor angiogenesis